Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-09-000578
Filing Date
2009-06-10
Accepted
2009-06-10 18:14:43
Documents
1
Period of Report
2009-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6065
  Complete submission text file 0001123292-09-000578.txt   8149
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 125 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 125 UNIVERSITY AVE PALO ALTO CA 94301
Skyline Venture Partners Qualified Purchaser Fund IV L P (Reporting) CIK: 0001324617 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 09885608